Industry Outlook
The primary factors driving the growth of the global fertility and pregnancy test kits market are the growing demand for self-contained solutions that the consumers can directly use, growing risk of infertility, and easy availability of time saving and cost-effective pregnancy detection solutions. In addition, increasing use of rapid testing kits in fertility clinics and home care, growing rate of adolescent pregnancies and high promotions of such solutions are some of the other factors supporting the market growth. On the other hand, lack of awareness about the availability of precise ovulation and fertility kits in low income countries, and questions raised on the precision of such devices, along with risk of false results due to improper use of pregnancy detection kits hold back the growth of this market. The major players in this industry are coming up with intensive marketing strategies, along with alliance with e-commerce platforms and distribution agreements with local players will open new opportunities in the emerging markets.
"Pregnancy Test Kits Segment to Dominate the Global Market"
Between fertility kits and pregnancy kits, the pregnancy test kits segment occupies over 50% of the global market share in 2020, and the segment is anticipated to lead the global market through the forecast period. The first pregnancy test kits and ovulation kits were approved (U.S.) in 1976 and 1984 respectively. Since the first approval, over 100 pregnancy tests and several home diagnostic solutions have been approved by the US FDA for assisting patients in diagnosis and monitoring of various conditions. Home diagnostic solutions are inexpensive and easy to use, therefore allow the patients to take the ownership of their health. Ovulation tests help women in augmenting their chance of conception. At home pregnancy kits allow women to detect pregnancy at earlier stages than waiting for physician appointment. Such early knowledge assists women to avoid activities that may be harmful for fetal development. Technological advancements have improved the ease of use and precision of pregnancy diagnostic kits.
"HCG tests Occupy the Largest Revenue Share, Globally"
Owing to the dominance of pregnancy tests in the global market, the dominance of HCG tests, both blood and urine based testing corresponds. These products are also in high demand as an alternative to the radiographic diagnostic solutions. The dose to the normal tissue with pregnancy kits is reduced, therefore minimizing the risk of radiation effects to the fetus and normal tissue. There are several pregnancy detection kits approved for sale in the global markets. Such tests vary in their sensitivity to detect hCG. Higher sensitivity kits are able to detect pregnancy earlier than the tests that detect hCG at 100 mIU/ml. hCG blood tests are more often used in healthcare settings such as clinics and hospitals as they are more sensitive and can deliver earlier prediction than urine tests.
"Asia Pacific to Account as the Fastest Market for Fertility and Pregnancy Test Kits"
North America and Western Europe together occupy the largest revenue shares in the global fertility and pregnancy kits market. The large share of this segment is attributed to growing use of fertility monitoring due to advancing maternity age, use of fertility monitoring for contraception and high awareness about the precision of ovulation monitors and pregnancy kits. On the other hand, Asia Pacific is anticipated to witness at the fastest CAGR during the forecast period. Competitive prices of pregnancy test kits, growing preference for at home monitoring of ovulation periods, and consistently increasing female population belonging to maternal age group are the key factors supporting the rapid pace of Asia Pacific market.
The major market players thus profiled in this report include Abbott Laboratories, Inc., Cardinal Health, Inc., Procter & Gamble Co., Swiss Precision Diagnostics GmbH, Germaine Laboratories, Inc., Church & Dwight Co., Inc., Piramal Healthcare (Piramal Enterprises Ltd.), Confirm Biosciences, Quidel Corporation, bioMérieux SA and Geratherm Medical AG.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Fertility And Pregnancy Test Kits market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2022-2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Year | 2022 |
| Unit | USD Million |
| Segmentation | |
Product
| |
Test
| |
Distribution Channel
| |
|
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report
